Search Results 281-290 of 16742 for alt

  1. A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety - Mayo Clinic

    ALT or AST > 3 times the upper limit of normal range, or severe hepatic impairment;; Hemoglobin < 100 g/L;; NT-proBNP ≥ 500 pg/mL. If one of these criteria ...

  2. Itraconazole Therapy In Bronchiectasis With Airway Mold - Mayo Clinic

    Abnormal baseline liver function tests (ALT, AST, alkaline phosphatase, or bilirubin >upper limit of normal). Prolonged QTc interval on baseline ECG (>460 ms ...

  3. Pediatric white blood cell disorders - Symptoms and causes - Mayo Clinic

    Eosinophils. Eosinophilia (e-o-sin-o-FIL-e-uh) is a having too many eosinophil cells. These cells help with swelling and irritation, called inflammation. They ...

  4. Study Of Cabozantinib Alone Or In Combination With Atezolizumab To Subjects With Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

    For subjects with HCC: ALT, AST, and ALP ≤ 5 × ULN. Total bilirubin ≤ 1.5 × ULN (for subjects with Gilbert's disease ≤3 × ULN). For subjects with HCC ...

  5. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

    Serum ALT/AST ≤ 2.5 x ULN; Total bilirubin ≤ 1.5 x ULN; Cardiac ejection fraction ≥ 50% and no clinically significant ECG findings; Baseline oxygen ...

  6. Fat Emulsion In Preventing Hypersensitivity Reactions In Patients With Cancer Receiving Carboplatin Or Oxaliplatin - Mayo Clinic

    Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 3 x the upper limit of normal; Triglycerides < 500 mg/dL; Alkaline phosphatase =< 3 x the ...

  7. A Safety Study of SGN-CD19A for Leukemia and Lymphoma - Mayo Clinic

    Baseline ALT and AST < 3 ULN. Exclusion Criteria: Allogeneic stem cell transplant within 60 days, active acute or chronic graft-versus-host disease (GvHD) ...

  8. Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer - Mayo Clinic

    Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≤ 2 x ULN; Albumin ≥ 3 g/dl; Serum testosterone ≤ 50 ng/dL (1.7 nmol/L). Participating ...

  9. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    AST/ALT ≤ 2.5 x upper limit of normal (ULN);; Bilirubin ≤ 2 x upper limit of normal (ULN) (unless documented Gilbert's Syndrome, for which Bilirubin ≤ 3 x ...

  10. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

    AST or ALT >5 times UNL; For HCC: Serum bilirubin >2.0 mg/dl (unless segmental infusion is planned47); For other primary or secondary liver neoplasis ...